NCT01969669 2017-11-20
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199
AbbVie
Phase 1 Completed
AbbVie
GlaxoSmithKline
Seagen Inc.
Eisai Inc.
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Bristol-Myers Squibb